phio: the income statement

MyFinsight

Phio Pharmaceuticals Corp. (PHIO)

For the quarter ending 2025-06-30, PHIO made $143K in revenue. -$2,166K in net income. Net profit margin of -1514.69%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

	2025-06-30
Research and development	1,074
General and administrative	1,235
Total operating expenses	2,309
Operating loss	-2,309
Total other income (expense), net	143
Net loss	-2,166

Net loss per common share, basic	-0.45
Net loss per common share, diluted	-0.45
Weighted average number of common shares outstanding, basic	4,794,857
Weighted average number of common shares outstanding, diluted	4,794,857

Unit: Thousand (K) dollars (except for numbers of shares and EPS)